NO884494L - Isoton w-3-fettsyreholdig fettemulasjon og anvendelse derav. - Google Patents

Isoton w-3-fettsyreholdig fettemulasjon og anvendelse derav.

Info

Publication number
NO884494L
NO884494L NO88884494A NO884494A NO884494L NO 884494 L NO884494 L NO 884494L NO 88884494 A NO88884494 A NO 88884494A NO 884494 A NO884494 A NO 884494A NO 884494 L NO884494 L NO 884494L
Authority
NO
Norway
Prior art keywords
fatty acids
omega
triunsaturated
eicosanoids
triglycerides
Prior art date
Application number
NO88884494A
Other languages
English (en)
Norwegian (no)
Other versions
NO884494D0 (no
Inventor
Joerg Nehne
Michael Boll
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6337948&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO884494(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of NO884494D0 publication Critical patent/NO884494D0/no
Publication of NO884494L publication Critical patent/NO884494L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO88884494A 1987-10-09 1988-10-07 Isoton w-3-fettsyreholdig fettemulasjon og anvendelse derav. NO884494L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3734147A DE3734147C2 (de) 1987-10-09 1987-10-09 Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung

Publications (2)

Publication Number Publication Date
NO884494D0 NO884494D0 (no) 1988-10-07
NO884494L true NO884494L (no) 1989-04-10

Family

ID=6337948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884494A NO884494L (no) 1987-10-09 1988-10-07 Isoton w-3-fettsyreholdig fettemulasjon og anvendelse derav.

Country Status (8)

Country Link
US (1) US5874470A (fi)
EP (1) EP0311091B1 (fi)
AT (1) ATE90559T1 (fi)
DE (2) DE3734147C2 (fi)
DK (1) DK563388A (fi)
ES (1) ES2058205T3 (fi)
FI (1) FI884617A (fi)
NO (1) NO884494L (fi)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
DE3903057A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
DE3903056A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
DE4133694C2 (de) * 1991-10-11 1993-10-07 Fresenius Ag Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
WO1993021912A1 (de) * 1992-04-28 1993-11-11 Fresenius Ag Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
EP0689835A3 (en) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition containing an amino acid mixture and at least one N-3 fatty acid
DE19501288A1 (de) * 1995-01-18 1996-07-25 Beiersdorf Ag Fettsäurederivate enthaltende Lotionen
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
WO1996029895A1 (de) 1995-03-31 1996-10-03 Schuer Joerg Peter Verfahren zur haltbarkeitsverbesserung und/oder stabilisierung von mikrobiell verderblichen produkten
BR9611826A (pt) † 1995-11-28 1999-07-13 Braun Melsungen Ag Emulsões de lipído otimizadas quanto a hidrólise e seu uso
DE19629433A1 (de) * 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
EP0843972B1 (en) * 1996-11-20 2002-07-31 N.V. Nutricia Nutritional composition comprising fats for the treatment of the metabolic syndrome
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
DE19931185A1 (de) 1999-07-07 2001-01-18 Joerg Peter Schuer Verfahren zur Entkeimung von Luft
DE19940605A1 (de) 1999-08-27 2001-03-01 Joerg Peter Schuer Imprägnierungsverfahren
DE10010127B4 (de) * 2000-03-03 2007-12-13 Wedeco Ag Water Technology UV-Bestrahlungsvorrichtung für die Behandlung von Abwasser
CA2413109C (en) * 2000-06-26 2007-11-27 Martek Biosciences Boulder Corporation Improved methods of incorporating polyunsaturated fatty acids in milk
NO313934B1 (no) * 2001-03-15 2002-12-30 Pronova Biocare As Hudpleiemiddel i form av en emulsjon, fremgangsmåte for fremstilling av nevnte hudpleiemiddel, samt anvendelse deav
US7799365B2 (en) * 2001-04-06 2010-09-21 Burnbrae Farms Limited Liquid egg composition including fish oil with omega-3 fatty acid
EP1279400A1 (en) 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
DE60221287T4 (de) * 2001-11-08 2009-06-25 Atrium Medical Corp. Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US8921422B2 (en) * 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
EP1684739A4 (en) 2003-11-12 2006-12-06 Childrens Medical Center TREATMENT AND PREVENTION OF PARENTERAL NUTRITION-RELATED LIVER DISEASE (PN)
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8263102B2 (en) * 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US9801982B2 (en) * 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
WO2006036984A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
US9012506B2 (en) * 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US20090011116A1 (en) * 2004-09-28 2009-01-08 Atrium Medical Corporation Reducing template with coating receptacle containing a medical device to be coated
GB0425658D0 (en) * 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
PT1800675E (pt) 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US8221809B2 (en) * 2006-06-22 2012-07-17 Martek Biosciences Corporation Encapsulated labile compound compositions and methods of making the same
EP2083875B1 (en) * 2006-11-06 2013-03-27 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) * 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
DE102008057867A1 (de) * 2008-11-18 2010-05-20 B. Braun Melsungen Ag Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011133841A2 (en) * 2010-04-23 2011-10-27 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Intravenous omega-3 fatty acid compositions & method of use
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
EP3099287A1 (en) * 2014-01-28 2016-12-07 Fresenius Kabi Deutschland GmbH Composition comprising epa and dha ethylester for parenteral administration
EP3099289B1 (en) 2014-01-28 2020-03-25 Fresenius Kabi Deutschland GmbH Composition comprising epa and dha triglycerides for parenteral administration
EP4450090A2 (en) 2017-08-10 2024-10-23 The Children's Medical Center Corporation Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
FR2515174A1 (fr) * 1981-10-23 1983-04-29 Roussel Uclaf Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
DE3475870D1 (en) * 1983-12-16 1989-02-09 Terumo Corp Transfusion emulsion
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response

Also Published As

Publication number Publication date
DE3734147C2 (de) 1998-10-29
EP0311091B1 (de) 1993-06-16
ES2058205T3 (es) 1994-11-01
ATE90559T1 (de) 1993-07-15
DE3734147A1 (de) 1989-04-20
DK563388D0 (da) 1988-10-07
DK563388A (da) 1989-04-10
US5874470A (en) 1999-02-23
FI884617A0 (fi) 1988-10-07
FI884617A (fi) 1989-04-10
DE3881815D1 (de) 1993-07-22
NO884494D0 (no) 1988-10-07
EP0311091A1 (de) 1989-04-12

Similar Documents

Publication Publication Date Title
NO884494L (no) Isoton w-3-fettsyreholdig fettemulasjon og anvendelse derav.
Ziboh et al. Dose-response effects of dietary γ-linolenic acid—enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4
ES2173673T3 (es) Mezcla grasa y agentes dieteticos o farmaceuticos que las contienen.
GR1000567B (el) Συνθεσις λιπαρου οξεος.
DK1121115T4 (da) PUFA-tilskud
NZ299464A (en) Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea
LU90401I2 (de) Omegaven
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
GR3006068T3 (fi)
PT843972E (pt) Composicao nutritiva que inclui gorduras para o tratamento do sindrome metabolico
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
DE3470277D1 (en) Dietetic composition
DK1027831T3 (da) Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne
ES2037265T3 (es) Nuevo aceite dietetico.
EP0283140B1 (en) Compositions and method for treatment of peptic ulcers
Becker Comparative uptake in rats and man of ω3 and ω6 fatty acids
Becker Comparative uptake in rats and man of w3 and w6 fatty acids
CIS Cardio-protective effect
TH15808A (th) ไทรกลีเซอไรด์ กรรมวิธีสำหรับการผลิต c-ซับสทิทิวเทดไดเอธิลีนไทรแอมีน